Kristal, Alan R <br/><br/>
Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.  [electronic resource] 

 -  American journal of epidemiology  Dec 2008 
 - 1416-24 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-6256 
<br/><br/><label>Standard No.: </label>10.1093/aje/kwn272  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Finasteride--therapeutic use<br/>Follow-Up Studies<br/>Gonadal Steroid Hormones--blood<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Prevalence<br/>Prognosis<br/>Prostatic Hyperplasia--blood<br/>Prostatic Neoplasms--blood<br/>Retrospective Studies<br/>Sex Hormone-Binding Globulin--metabolism<br/>Surveys and Questionnaires<br/>Time Factors<br/>United States--epidemiology